Ligand validation:1PXI

CK1: 4-(2,5-DICHLOROTHIEN-3-YL)PYRIMIDIN-2-AMINE

CK1 is a Ligand Of Interest in 1PXI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1PXI_CK1_A_500	27%	3%	0.177	0.824	2.66	3.34	6	4	0	0	100%	0.73

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.